microvesicle

mi·cro·ves·i·cle

(mī'krō-ves'i-kĕl),
A fluid-filled space formed within the epidermis that is too small to be recognized as a blister.
References in periodicals archive ?
The new study builds upon a series of previously published studies in which NX Prenatal has demonstrated that the enrichment of exosome and microvesicle particles from maternal blood and subsequent proteomic analysis enables risk stratification of spontaneous preterm birth in the first trimester of pregnancy.
In addition, it was demonstrated that the exosome release in pathogenic form is upregulated in association with PD mutated genes, like LRRK2 and ATP13A2, that acts in modulating microvesicle biogenesis and trafficking.
How is microvesicle formed and what is the content inside becomes a very hot topic attracting massive interest from scientist worldwide during the recent years.
Along with multicolor performance, flow cytometry has proven to be a valuable tool in small particle research, which is growing exponentially along with the medical research field's understanding of microvesicle and exosome native biology and their potential applications in diagnostics and therapeutics.
Smoking alters circulating plasma microvesicle pattern and microRNA signatures.
Bailey et al., "The influence of membrane physical properties on microvesicle release in human erythrocytes," PMC Biophysics, vol.
Exosome Microvesicle, ectosome, shedding vesicles Size 40-100 nm 100-1000 nm Markers CD63, CD9, Alix, Anexin V, Flotillin-2, TSG 101, HSP 70 selectin, integrin, CD40 metalloproteinase Isolation Immunoprecipitation Ultracentrifugation method (ExoQuick[R]) (10,000-60,000 g) ultracentrifugation (100,000-200,000 g), ultracentrifugation with density gradient References 49,53 54 Apoptotic bodies Size 1000-5000 nm Markers Anexin V, DNA, histones Isolation No standardized protocol method References 55
Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes.
The instrument can visualize and measure particles in suspension in the size range 10 to 2000 nm (depending on material) and addresses the needs of a variety of applications, including protein aggregation, exosome and microvesicle research, drug delivery systems and characterization of materials under the EU Definition of Nanomaterials.
The deal excludes the molecular profiling service Caris Target Now and the circulating microvesicle technology Carisome.
However, in 1987 a new non-phospholipid microvesicle was developed and marketed under the Novasome brand name.